Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects

Biomarkers

Volumn 15, Issue 2, 2010, Pages 140-148

  Hosnijeh, Fatemeh Saberi ^a,b   Krop, Esmeralda J M ^a   Portengen, Lützen ^a   Rabkin, Charles S ^c   Linseisen, Jakob ^d   Vineis, Paolo ^e   Vermeulen, Roel ^a,f  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL CANCER INSTITUTE   (United States)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokine; Freeze thaw cycle; Reproducibility

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CITRIC ACID; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; FREEZE THAWING; HUMAN; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; REPRODUCIBILITY; SERUM;

ADULT; ANTICOAGULANTS; BLOOD SPECIMEN COLLECTION; CHEMOKINES; CITRIC ACID; CRYOPRESERVATION; CYTOKINES; DRUG STABILITY; FREEZING; HEPARIN; HUMANS; PLASMA; REPRODUCIBILITY OF RESULTS; SERUM; SPECIMEN HANDLING;

EID: 77249117338     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903340570     Document Type: Article

References (21)

1. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. (1999a). Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 6:89-95.
2. Aziz N, Nishanian P, Taylor JMG, Mitsuyasu RT, Jacobson JM, Dezube BJ, Lederman MM, Detels R, Fahey JL. (1999b). Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. J Infect Dis 179:843-8.
3. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. (2003). Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10:133-9.
4. de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT. (2005). Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Meth 300:124-35.
5. de Jager W, Rijkers GT. (2006). Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 38:294-303.
6. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. (2000). Effect of sample handling on the stability of interlukin-6, tumor necrosis factor-α and leptin. Cytokine 12:1712-16.
7. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-32.
8. Helsel DR. (1990). Less than obvious- statistical treatment of data below the detection limit. Environ Sci Technol 24:1766-74.
9. Helsel DR. (2005). More than obvious: better methods for interpreting nondetect data. Environ Sci Technol 39:419-23A.
10. Holland NT, Smith MT, Eskenazi B, Bastaki M. (2003). Biological sample collection and processing for molecular epidemiological studies. Mutat Res 543:217-34.
11. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE. (2001). Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45:27-36.
12. Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S. (2006). Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107:4101-8.
13. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, Bernstein L, Hartge P. (2004). Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Prospect 112:1691-6.
14. Pfleger C, Schloot N, ter Veld F. (2008). Effect of serum content and diluent selection on assay sensitivity and signal intensity in multiplex bead-based immunoassays. J Immunol Methods 329:214-18.
15. Ray CA, Bowsher RR, Smith WC, Devanarayan V, Willey MB, Brandt JT, Dean RA. (2005). Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J Pharm Biomed Anal 36:1037-44.
16. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, and others (2006). Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphomas: a report from InterLymph Consortium. Lancet Oncol 7:27-38.
17. Steinman L. (2007). A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139-45.
18. Tworoger SS, Hankinson SE. (2006). Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev 15:1578-81.
19. Vignali DA. (2000). Multiplexed particle-based flow cytometric assays. J Immunol Methods 243:243-55.
20. Vineis P, Perera F. (2007). Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 16:1954-65.
21. Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS. (2008). Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 17:3450-6.